[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365223-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365223-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","research-progress-of-gpr137-in-malignant-tumors-a-review","Research Progress of GPR137 in Malignant Tumors - A Review","","Receptors coupled with G proteins (GPCRs) are widely expressed across endocrine, cardiovascular, digestive, immune, and reproductive systems, where they act as key signal transduction mediators. In gastrointestinal, reproductive, and urinary contexts, GPCRs contribute to cancer development and relate to malignant infiltration and metastasis. Orphan GPCRs (OGPCRs) lack known ligands yet show regulatory roles in crucial physiological functions and represent potential therapeutic targets. GPR137, an OGPCR member, is elevated in malignant tissues and promotes tumorigenesis and metastasis across multiple cancers. GPR137 knockdown induces cell-cycle arrest, suppresses proliferation and colony formation, and promotes apoptosis, supporting its therapeutic value.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/research-progress-of-gpr137-in-malignant-tumors-a-review/365223/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/research-progress-of-gpr137-in-malignant-tumors-a-review/365223.png","ImageObject",300,407,{"name":42,"@type":43},"Mia  ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the role of GPCRs in malignant tumors according to the review?","Question",{"text":63,"@type":64},"GPCRs are linked to cancer development and are associated with malignant infiltration and metastasis in gastrointestinal, reproductive, and urinary systems.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why are orphan GPCRs considered important research targets?",{"text":68,"@type":64},"Orphan GPCRs (OGPCRs) lack known ligands, but animal and experimental research indicates they regulate crucial physiological functions and may serve as undeveloped therapeutic targets.",{"name":70,"@type":61,"acceptedAnswer":71},"How does GPR137 affect cancer cells and treatment potential?",{"text":72,"@type":64},"GPR137 expression is elevated in various malignant tumors and promotes tumorigenesis and metastasis; knockdown causes cell-cycle arrest, inhibits proliferation and colony formation, and promotes apoptosis, highlighting therapeutic significance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365223,1790194946,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","OncoTargets and Therapy  \nOpen Access Full Text Article REVIEW  \nResearch Progress of GPR137 in Malignant Tumors: A Review  \nYangyang Li 1 , *, ZhongQuan Yi2 , *, Xia Li 3 , *, Rui Wang 1 , Mengjie Zhao 1 , Lida Mi 1 , Weisong Zhang 1 , Rongqi Guo 1 , Song Yan4 , JianXiang Song 1  \n1Department of Cardiothoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng, 224000, People’s Republic of China; 2Department of Central Laboratory, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng, 224000, People’s Republic of China; 3Department of General Medicine, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng, 224000, People’s Republic of China; 4Department of Thoracic Surgery, Sheyang County People’s Hospital, Yancheng, Jiangsu, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: JianXiang Song, Department of Cardiothoracic Surgery, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, West Xindu Road 2\\#, Yancheng, Jiangsu Province, 224000, People’s Republic of China, Email [jxsongycsy@163.com](jxsongycsy@163.com)  \n\n| Abstract: Receptors coupled with G proteins (GPCRs) are expressed in large numbers in multiple systems, such as endocrine, cardiovascular, digestive, immune, and reproductive systems. As an important signal transduction mediator, in recent years, the research on GPCRs has become more and more in-depth. Many articles have verified that in the gastrointestinal, reproductive, and urinary systems, GPCRs are contributed to the development and occurrence of cancerous tumors and have been associated with the infiltration of malignant tumors and metastasis. Currently, in clinical practice, GPCRs become the target of action for about 30% of drugs. However, it should be noted that there are still over 100 GPCRs collectively referred to as orphan GPCRs (OGPCRs) due to the lack of corresponding ligands. Despite the lack of known ligands, research in animals and experiments has proved that numerous OGPCRs regulate crucial physiological functions and are intriguing and undeveloped targets for therapeutics. GPR137 is a member of OGPCRS, which promotes carcinogenesis and progression of cancers, and its expression is elevated in various malignant tumor tissues. Additionally, GPR137 has been shown to play a role in promoting tumorigenesis and metastasis in colorectal, gastric, hepatocellular, ovarian and prostate cancers. Knockdown of the GPR137 leads to cell cycle arrest within cancer cells, effectively inhibiting their proliferation and colony-forming ability while promoting apoptosis. This highlights its potential therapeutic significance as a target for numerous cancers.\u003Cbr>Keywords: malignant tumors, G protein-coupled receptor, GPR137, molecular targeting treatment |\n| --- |\n| Introduction\u003Cbr>Malignant tumors are considered a serious public health threat and are the leading cause of death worldwide.1,2 Based on estimates of cancer incidence and mortality rates compiled by the International Agency for Research on Cancer (IARC) in GLOBOCAN 2022, roughly 20 million people were diagnosed with malignant tumors and almost 9.7 million died of malignant tumors globally in the year 2022.3 There is evidence that the “history” of malignant tumors goes back a million years, and that cellular organisms have been afflicted by the disease for nearly 200 million years.4 Malignant tumors differ from infectious diseases and diseases of the immune system. The pathogenesis of malignant tumors is characterized by uncontrolled cell proliferation and growth. Tumor cells undergo genetic damage while proliferating indefinitely, spreading widely and invading surrounding tissues, resulting in the loss of normal physiological and regulatory functions.4 With advancements in modern medicine, cell and molecular studies have delved deeper into various molecules or proteins that ","cbCailVm1oxE3BW0","https://ap.wps.com/l/cbCailVm1oxE3BW0","pdf",1874004,14,"English","# Introduction\n## Malignant tumors and molecular markers\n# GPR137 as an orphan GPCR\n## Therapeutic implications","[{\"question\":\"What is the role of GPCRs in malignant tumors according to the review?\",\"answer\":\"GPCRs are linked to cancer development and are associated with malignant infiltration and metastasis in gastrointestinal, reproductive, and urinary systems.\"},{\"question\":\"Why are orphan GPCRs considered important research targets?\",\"answer\":\"Orphan GPCRs (OGPCRs) lack known ligands, but animal and experimental research indicates they regulate crucial physiological functions and may serve as undeveloped therapeutic targets.\"},{\"question\":\"How does GPR137 affect cancer cells and treatment potential?\",\"answer\":\"GPR137 expression is elevated in various malignant tumors and promotes tumorigenesis and metastasis; knockdown causes cell-cycle arrest, inhibits proliferation and colony formation, and promotes apoptosis, highlighting therapeutic significance.\"}]","Research Progress of GPR137 in Malignant Tumors - A Review | PDF",1790160382,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28c9edf5bb3009bb391d02ecb734a949.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c22ffecc384046e842c2cf33d74e5df1.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b71adc093362b189dfb63741a716e6f.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/736b003d7be6317a6b63d0f7a8632ab9.webp",980,1268]